All News #Library
Biotech
Synox Therapeutics Reports Phase 3 TANGENT Study Success
13 Apr 2026 //
GLOBENEWSWIRE
Synox Therapeutics Bolsters Board With Commercialization
21 Oct 2025 //
GLOBENEWSWIRE
SynOx Therapeutics Gets Fast Track for Emactuzumab for TGCT Tumours
14 Apr 2025 //
GLOBENEWSWIRE
SynOx Therapeutics Announces Board Chair Transition for Strategy
01 Apr 2025 //
GLOBENEWSWIRE
SynOx Secures $35M Debt For Emactuzumab Commercialization
30 Apr 2024 //
PR NEWSWIRE

Market Place
Sourcing Support